Tumor Biology and Immunology Doctorate Degree Program
Academic Unit Presenting the Program
Tumor Biology and Immunology
Program Director
Head of Department Assoc. Prof. Dr. Bahadır BATAR
Institute Director Prof. Dr. Selami GÜRKAN
Institute Deputy Director Assoc. Prof. Dr. Birol TOPÇU
Institute Deputy Director Assoc. Prof. Dr. Serhat ÖRÜN
Program Type
Doctorate Degree Program
Level of Degree Earned
Doctorate
Degree Earned
Upon graduation, you will receive a PhD in Tumor Biology and Immunology.
Education Type
Tam Zamanlı
Registration Acceptance Conditions
In order to apply to the Tumor Biology and Immunology PhD program, candidates must;
a) Be a graduate of the Faculty of Medicine or a graduate of the Departmental Master's program of the Faculty of Medicine, Veterinary Medicine or Pharmacy; have a master's degree in Medical Biology, Biotechnology, Biochemistry, Molecular Biology, Molecular Medicine, Immunology, Genetics, Basic Oncology or have a specialist authority in a laboratory branch according to the principles regulated by the Ministry of Health and have at least 55 standard points in the numerical score type from ALES or be successful in internationally accepted exams whose equivalence is accepted by the Senate instead of the ALES result and whose success base points are determined, and those who apply with a bachelor's degree must have at least 80 standard points in the numerical score type from ALES. Those who apply to the PhD program with a bachelor's degree must have a bachelor's graduation grade point average of at least 3 out of 4 or an equivalent score.
b) In order to apply to the PhD program in basic medical sciences; medical school graduates must have a bachelor's degree and a minimum of 50 basic medical score or a minimum of 70 standard score in the numerical score type from ALES or be successful in internationally accepted exams whose equivalence is accepted by the Senate instead of the ALES result and whose success base scores are determined. The Basic Medical score is obtained by multiplying the standard score obtained from the (TUS) Basic Medical Sciences Test Part I by 0.7 and the standard score obtained from the Clinical Medical Sciences Test by 0.3 and adding them together.
c) In order to apply to the doctoral program, a minimum score of 55 from YDS or an equivalent score from an exam accepted by the Interuniversity Board is required, and for foreign students, a minimum score of 55 from YDS or an equivalent score from an exam accepted by the Interuniversity Board in a language other than their mother tongue, such as English, French or German, is required, and the Senate is authorized to increase the aforementioned minimum scores according to the characteristics of the programs to be entered.
Achievement grade in student admission to doctoral programs; The undergraduate degree is calculated by adding 20% of the undergraduate weighted GPA for applicants with a bachelor's degree, 50% of the standard score from ALES, and 30% of the score obtained as a result of the interview conducted by the jury established by the institute's board of directors for each department. In order for a candidate to be considered successful, the success grade must be at least 70. Students are accepted as many as the announced quota by ranking from the highest score to the lowest.
Recognition of Prior Learning
Successful students who have completed at least one semester in another department of the relevant university or institute of technology or in a postgraduate program of another higher education institution may apply for the horizontal transfer quota announced in the relevant department. Horizontal transfer is possible with the approval of the relevant department head and the decision of the institute's board of directors.
Degree Requirements and Rules
The students studying in this Ph.D program are required:
to take a minimum of 7 courses with a minimum of 21 local credits
to pass the qualifying examination,
to prepare and defend a doctoral dissertation
to succeed in all the courses with a letter grade of at least CB/S
to have a Cumulative Grade Point Average of at least 2.50/4.00 with a minimum of 240 ECTS credits.
Program Profile
The Tumor Biology and Immunology PhD Program accepted its first students in the Fall Semester of the 2017-2018 Academic Year. Education and research activities in the program continue with 1 professor, 2 associate professors and 6 assistant professors. The language of instruction is Turkish. The program includes compulsory and elective courses related to the field of Tumor Biology and Immunology. Compulsory and elective courses related to the field are taken in the 1st, 2nd, 3rd and 4th semesters; thesis work related to the field is carried out in the 5th, 6th, 7th and 8th semesters.
Occupational Profiles of Graduates
Graduates can become researchers and academicians in the basic medical departments of science faculties and medical faculties; they can take part in diagnosis and treatment processes, especially in areas related to cancer, they can conduct scientific studies in these areas and participate in studies. They can find jobs in the private sector in the pharmaceutical sector, biomedical companies and companies working in the field of biotechnology.
Access To Upper Degree
Graduates who successfully complete their doctoral education can receive further training in the same or similar fields at relevant centers in Turkey and abroad, particularly in order to conduct research and development studies and develop products; it is expected that this training will be more application-oriented in the field of biotechnology.
Exams, Assessment and Grading
To be considered successful, the success grade must be at least 75 points in the doctoral program.
Graduation Requirements
Teaching Methods
Presentation, Seminar, literature presentation, small group work, problem solving, individual work, laboratory work, homework
Program Outcomes
1-Recognizing that components of the immune system to understand the mechanisms of immune response in case of cancer ocur 2-Identification of individual genetic risk factors and planning of treatment according to genetic characteristics of cancer cells 3-The cancer burden in our country and in the world that arise by determining the types and levels of information about cancer by gender 4-To acquire theoretical and practical information about basic techniques applied in immunology laboratory 5-The conventional treatment used in the fight against cancer current treatment methods that are applied in addition to have knowledge about 6-Understanding which antigens the cancer cells differ from normal tissue and how these antigens are recognized by the immune system 7-Have knowledge about important factors in the development of metastasis 8-Cancer cells that contribute to tumor formation as well as tumor micro-environment is located in cancer cells and non-cells and their functions to understand 9-The experiment is done by observing the most frequently used techniques in molecular biology laboratories to understand how these techniques and gain knowledge and skills 10-Unlike normal cells, how cancer cells proliferate and understand the metabolic changes that result from cancer 11-Transformation of normal cells into cancer cells and the mechanisms of this process is understanding the role in carcinogenesis of the normal cell cycle 12-Oncogenesis with these viruses tumor viruses and that plays a role is to obtain information about the relationship between the formation of cancer 13-To learn the basic concepts in the field of Oncology 14-Related to basic cell biology underlying the mechanisms of cancer at the cellular level by learning the changes, try to understand 15-Changes of gene expression in cancer the genetic changes underlying the formation of tumor targeted cancer molecules in the diagnosis and treatment of issues, the selection of knowledge 16-Understanding the functions of tumor formation and the effective factors 17-Molecular genetic and immunological parameters of the tumor is transferred to the data base and the relations between them and the emergence of cancer and in the process will be done, and haplotyping to obtain information such as pathway analysis 18-Basic transplantation Immunology and transplantation must be known in order to perform suitable information to understand the mechanisms that play a role in the development of projection
Curriculum
Tumor Biology and Immunology
Yüksek Lisansda açılan dersler Doktora için de seçilebilir.
Course
2024-2025 Fall Semester
Course Code
Course Name
Browse
T
A
ECTS
TBIDK612
Cancer Immunology and Immunotherapy I
3
6
5
TBIDK613
Cancer Immunology and Immunotherapy II
2
6
5
TBIDK633
Cancer Metabolism
3
0
5
TBIDK604
Cancer Root Cell
3
0
5
TBIDK614
Cancer Therapy Principles; Mechanisms of Impact and Resistance
3
0
5
TBIDK603
Cell Signaling
3
0
5
TBIDK607
Introduction to Biotechnology
3
0
5
TBIDK608
Molecular and Genetic Markers in Cancer
3
0
5
TBIDK602
Molecular Oncology I
3
0
5
TBIDK606
Molecular Oncology II
3
0
5
LÜ SBEDR09
Scientific Research Methods Research and Publication Ethics
1
2
5
LÜ SBEDR 03
Special Topics
8
0
10
TBIDK609
Tissue Compatibility Antigens
3
0
5
TBIDK605
Tumor and Immunological Laboratory Techniques I
1
6
5
TBIDK610
Tumor and Immunological Laboratory Techniques II
1
6
5
TBIDK611
Tumor Microcooling
3
0
5
Elective
2024-2025 Güz Tümör Biyolojisi ve İmmünolojisi (Tıp) Doktora Seçmeli Dersleri()
25
TBDK626
Cancer Epidemiology and Etiology
3
0
5
TBIDK627
Cell-Level Cancer Imaging Methods
3
0
5
TBIDK628
Effect of Cancer Stem Cells on Treatment Strategies
3
0
5
TBIDK625
Gene Therapy
3
0
5
TBIDK634
Immunotoxicology
2
0
5
TBIDK637
Molecular Pathology of Cancer
3
2
5
TBIDK635
Oncogenic and Oncolytic Viruses
2
0
5
TBIDK629
The Importance of Molecular Biology in Cancer
3
0
5
Total ECTS:
110
2024-2025 Spring Semester
Course Code
Course Name
Browse
T
A
ECTS
TBIDK604
Cancer Root Cell
3
0
5
TBIDK614
Cancer Therapy Principles; Mechanisms of Impact and Resistance
3
0
5
LÜ SBEDR 04
Seminar
0
2
5
LÜ SBEDR 03
Special Topics
8
0
10
TBIDK609
Tissue Compatibility Antigens
3
0
5
Elective
2024-2025 BAHAR YARIYILI TÜMÖR BİYOLOJİSİ VE İMMÜNOLOJİSİ (TIP) DOKTORA PROGRAMI SEÇMELİ DERSLER()
25
TBDK626
Cancer Epidemiology and Etiology
3
0
5
TBIDK627
Cell-Level Cancer Imaging Methods
3
0
5
TBIDK628
Effect of Cancer Stem Cells on Treatment Strategies
3
0
5
TBIDK625
Gene Therapy
3
0
5
TBIDK637
Molecular Pathology of Cancer
3
2
5
TBIDK629
The Importance of Molecular Biology in Cancer
3
0
5
Total ECTS:
55
Total ECTS(Year):
165
Thesis
2024-2025 Fall Semester
Course Code
Course Name
Browse
T
A
ECTS
LÜ SBEDR 03
Special Topics
8
0
10
LÜ SBEDR 06
Thesis Work
1
0
20
LÜ SBEDR 07
Thesis Writing and Conclusion Report
1
0
5
Total ECTS:
35
2024-2025 Spring Semester
Course Code
Course Name
Browse
T
A
ECTS
LÜ SBEDR 03
Special Topics
8
0
10
LÜ SBEDR 06
Thesis Work
1
0
20
LÜ SBEDR 07
Thesis Writing and Conclusion Report
1
0
5
Total ECTS:
35
Total ECTS(Year):
70
Doctoral Qualification
2024-2025 Fall Semester
Course Code
Course Name
Browse
T
A
ECTS
LÜ SBE 04
Special Topics
8
0
10
Total ECTS:
10
Total ECTS(Year):
10
Matrix of Course - Program Outcomes
TBIDK612 Cancer Immunology and Immunotherapy I
#
5
2
2
2
3
5
2
1
1
2
2
2
2
2
2
2
3
2
5
2
2
2
3
5
2
1
1
2
2
2
2
2
2
2
3
2
5
2
2
2
3
5
2
1
1
2
2
2
2
2
2
2
3
2
5
2
2
2
3
5
2
1
1
2
2
2
2
2
2
2
3
2
5
2
2
2
3
5
2
1
1
2
2
2
2
2
2
2
3
2
5
2
2
2
3
5
2
1
1
2
2
2
2
2
2
2
3
2
TBIDK613 Cancer Immunology and Immunotherapy II
#
4
1
1
3
3
3
2
3
2
2
1
2
1
2
2
1
2
1
4
1
1
3
3
3
2
3
2
2
1
2
1
2
2
1
2
1
4
1
1
3
3
3
2
3
2
2
1
2
1
2
2
1
2
1
4
1
1
3
3
3
2
3
2
2
1
2
1
2
2
1
2
1
4
1
1
3
3
3
2
3
2
2
1
2
1
2
2
1
2
1
4
1
1
3
3
3
2
3
2
2
1
2
1
2
2
1
2
1
4
1
1
3
3
3
2
3
2
2
1
2
1
2
2
1
2
1
TBIDK633 Cancer Metabolism
#
4
5
4
3
2
2
4
5
3
4
4
3
2
4
3
5
2
1
TBIDK604 Cancer Root Cell
#
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
3
4
1
1
3
2
4
1
1
4
3
2
1
1
TBIDK614 Cancer Therapy Principles; Mechanisms of Impact and Resistance
#
1
1
1
1
5
1
1
1
1
5
3
1
3
2
1
2
1
1
1
1
1
1
5
1
1
1
1
5
3
1
3
2
1
2
1
1
TBIDK603 Cell Signaling
#
1
3
3
2
1
1
2
1
1
1
3
1
5
1
1
1
1
1
1
3
3
2
1
1
2
1
1
1
3
1
5
1
1
1
1
1
1
3
3
2
1
1
2
1
1
1
3
1
5
1
1
1
1
1
TBIDK607 Introduction to Biotechnology
#
1
3
1
3
4
4
1
4
4
1
1
5
1
1
3
2
1
1
TBIDK608 Molecular and Genetic Markers in Cancer
#
1
4
1
1
1
1
1
3
1
1
1
1
3
1
1
1
1
1
1
4
1
1
1
1
1
3
1
1
1
1
3
1
1
1
1
1
TBIDK602 Molecular Oncology I
#
1
1
3
1
5
4
5
1
1
5
5
3
5
5
5
4
1
1
1
1
3
1
5
4
5
1
1
5
5
3
5
5
5
4
1
1
1
1
3
1
5
4
5
1
1
5
5
3
5
5
5
4
1
1
1
1
3
1
5
4
5
1
1
5
5
3
5
5
5
4
1
1
1
1
3
1
5
4
5
1
1
5
5
3
5
5
5
4
1
1
TBIDK606 Molecular Oncology II
#
1
4
3
1
5
3
5
1
1
5
5
5
5
5
5
5
1
1
1
4
3
1
5
3
5
1
1
5
5
5
5
5
5
5
1
1
1
4
3
1
5
3
5
1
1
5
5
5
5
5
5
5
1
1
1
4
3
1
5
3
5
1
1
5
5
5
5
5
5
5
1
1
1
4
3
1
5
3
5
1
1
5
5
5
5
5
5
5
1
1
1
4
3
1
5
3
5
1
1
5
5
5
5
5
5
5
1
1
LÜ SBEDR09 Scientific Research Methods Research and Publication Ethics
#
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
TBIDK609 Tissue Compatibility Antigens
#
3
1
1
1
1
5
1
1
1
1
1
1
1
1
1
1
1
5
3
1
1
1
1
5
1
1
1
1
1
1
1
1
1
1
1
5
TBIDK605 Tumor and Immunological Laboratory Techniques I
#
2
1
1
5
1
1
1
4
5
1
1
1
1
1
1
1
1
4
2
1
1
5
1
1
1
4
5
1
1
1
1
1
1
1
1
4
2
1
1
5
1
1
1
4
5
1
1
1
1
1
1
1
1
4
TBIDK610 Tumor and Immunological Laboratory Techniques II
#
3
4
1
5
1
3
1
1
5
3
1
1
1
1
3
1
3
1
3
4
1
5
1
3
1
1
5
3
1
1
1
1
3
1
3
1
3
4
1
5
1
3
1
1
5
3
1
1
1
1
3
1
3
1
3
4
1
5
1
3
1
1
5
3
1
1
1
1
3
1
3
1
TBIDK611 Tumor Microcooling
#
2
1
1
1
3
4
2
1
1
3
1
1
1
1
1
1
1
1
2
1
1
1
3
4
2
1
1
3
1
1
1
1
1
1
1
1
2
1
1
1
3
4
2
1
1
3
1
1
1
1
1
1
1
1
2
1
1
1
3
4
2
1
1
3
1
1
1
1
1
1
1
1
TBDK626 Cancer Epidemiology and Etiology
#
1
5
1
1
1
1
1
1
1
3
1
3
1
3
5
1
1
1
1
5
1
1
1
1
1
1
1
3
1
3
1
3
5
1
1
1
TBIDK627 Cell-Level Cancer Imaging Methods
#
1
2
1
1
3
1
3
1
1
4
4
1
1
5
1
2
1
1
1
2
1
1
3
1
3
1
1
4
4
1
1
5
1
2
1
1
1
2
1
1
3
1
3
1
1
4
4
1
1
5
1
2
1
1
TBIDK628 Effect of Cancer Stem Cells on Treatment Strategies
#
2
2
1
3
4
3
1
2
2
3
3
2
1
3
2
2
1
1
2
2
1
3
4
3
1
2
2
3
3
2
1
3
2
2
1
1
2
2
1
3
4
3
1
2
2
3
3
2
1
3
2
2
1
1
2
2
1
3
4
3
1
2
2
3
3
2
1
3
2
2
1
1
TBIDK625 Gene Therapy
#
1
4
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
TBIDK634 Immunotoxicology
#
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
TBIDK637 Molecular Pathology of Cancer
#
5
5
5
5
5
3
4
2
4
4
4
4
4
4
3
4
4
2
5
5
5
5
5
4
4
4
4
3
5
5
4
3
3
4
4
2
TBIDK635 Oncogenic and Oncolytic Viruses
#
1
4
1
1
4
1
1
1
1
1
1
5
1
1
1
2
1
1
TBIDK629 The Importance of Molecular Biology in Cancer
#
1
1
1
2
1
3
1
3
5
1
1
1
1
1
1
1
1
1
1
1
1
2
1
3
1
3
5
1
1
1
1
1
1
1
1
1
1
1
1
2
1
3
1
3
5
1
1
1
1
1
1
1
1
1
TBIDK604 Cancer Root Cell
#
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
4
4
1
1
3
2
4
1
1
4
3
2
1
1
3
3
1
3
3
4
1
1
3
2
4
1
1
4
3
2
1
1
TBIDK614 Cancer Therapy Principles; Mechanisms of Impact and Resistance
#
1
1
1
1
5
1
1
1
1
5
3
1
3
2
1
2
1
1
1
1
1
1
5
1
1
1
1
5
3
1
3
2
1
2
1
1
0
0
0
0
0
0
0
0
0
2
0
0
3
0
0
0
0
0
LÜ SBEDR 04 Seminar
#
1
2
3
1
3
2
1
2
1
1
1
1
4
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
TBIDK609 Tissue Compatibility Antigens
#
1
1
1
1
1
5
1
1
1
1
1
1
1
1
1
1
1
5
3
1
1
1
1
5
1
1
1
1
1
1
1
1
1
1
1
5
TBDK626 Cancer Epidemiology and Etiology
#
1
5
1
1
1
1
1
1
1
3
1
3
1
3
5
1
1
1
1
5
1
1
1
1
1
1
1
3
1
3
1
3
5
1
1
1
TBIDK627 Cell-Level Cancer Imaging Methods
#
1
2
1
1
3
1
3
1
1
4
4
1
1
5
1
2
1
1
1
2
1
1
3
1
3
1
1
4
4
1
1
5
1
2
1
1
1
2
1
1
3
1
3
1
1
4
4
1
1
5
1
2
1
1
TBIDK628 Effect of Cancer Stem Cells on Treatment Strategies
#
2
2
1
3
4
3
1
2
2
3
3
2
1
3
2
2
1
1
2
2
1
3
4
3
1
2
2
3
3
2
1
3
2
2
1
1
2
2
1
3
4
3
1
2
2
3
3
2
1
3
2
2
1
1
2
2
1
3
4
3
1
2
2
3
3
2
1
3
2
2
1
1
TBIDK625 Gene Therapy
#
1
4
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
TBIDK637 Molecular Pathology of Cancer
#
5
5
5
5
5
3
4
2
4
4
4
4
4
4
3
4
4
2
5
5
5
5
5
4
4
4
4
3
5
5
4
3
3
4
4
2
TBIDK629 The Importance of Molecular Biology in Cancer
